Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie 13. Décembre 2025
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Pancréas
Néoplasie
Pancréatite
Autres
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 2924  Page précédente Page suivante
   
   Articles 1 - 20 / 58462  
   
Deep learning to predict extrapancreatic perineural invasion at CT images.
Ann Med
Cai Z, Zou L, Li Q, Chen J, Qiu Y, Ji J, Mao L.
PMID: 41388696 [PubMed - indexed for MEDLINE]


A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2.
BJC Rep
Grindedal EM, Zucknick M, Hovland ST, Grimsrud TK, Mæhle L.
PMID: 41387549 [PubMed]


Nutrition in Hepatocellular Carcinoma: Pathophysiological Insights, Impact, and Implications for Clinical Practice.
J Gastroenterol Hepatol
Dirjayanto VJ, Yiu DSM, Chen R, Fan KH.
PMID: 41387249 [PubMed - as supplied by publisher]


Association between pancreatic enzyme replacement therapy and mortality in pancreatic cancer: a matched case-control study.
Pancreatology
Dugic A, Hagström H, Palmer I, Nouri A, Tari HT, Schmaderer L, Liljefors MG, Ghorbani P, Löhr JM, Vujasinovic M.
PMID: 41387158 [PubMed - as supplied by publisher]


The tumor microbiome and cancer immunotherapy: A systematic review of a new frontier beyond the gut.
Bull Cancer
Barjij I, Meliani M.
PMID: 41387030 [PubMed - as supplied by publisher]


Comparative Analysis of Fecal Microbiota in Healthy Controls and Pancreatic Cancer Patients: A Focus on Tumor Localization Differences in Pancreatic Head and Body-Tail.
Cancer Med
Villani A, Mencarelli G, Cocomazzi G, Binda E, Virgili E, Latiano TP, Maiello E, Contu V, Perri F, Panebianco C, Pazienza V.
PMID: 41386285 [PubMed - indexed for MEDLINE]


Cancer incidence, stage at diagnosis, and trends across the Navajo Nation, 2014-2018.
Cancer
Yazzie D, Pete D, Briscoe C, Jim MA, Meisner A, Wiggins C, Doyle D, Yee G, Goldtooth C, Sanderson PR, Keene CN, Smith M, Sehn H, Damon S, Kettering CL, Emerson M, Curley C, Bea J, Yazzie S, Joe N, Doherty J, Dirk de Heer H, Navajo Cancer Workgroup.
PMID: 41385397 [PubMed - indexed for MEDLINE]


A review, evaluation and content mapping study of Australian patient-facing online pancreatobiliary cancer resources.
Support Care Cancer
Ferrar K, Baggoley C, Beatty L, Brooke-Smith M, Han CY, Holz B, Koczwara B, Lee J, Paterson C, Wallen MP, Robertson A, Barreto SG.
PMID: 41385087 [PubMed - indexed for MEDLINE]


Large Language Model-Based Automated Tumor, Node, Metastasis Staging and Resectability Assessment for Pancreatic Cancer in Radiology Reports With Detection of Incomplete Documentation.
Cureus
Fujisawa S, Kurokawa R, Hagiwara A, Kurokawa M, Asari Y, Hatano S, Matsumoto D, Negishi A, Gonoi W, Abe O.
PMID: 41384206 [PubMed]


Compare the prognosis of pancreatic cancer patients with different treatment modalities and use machine learning methods to build predictive models.
Front Med (Lausanne)
Fan L, Kong S, Deng Y, Wang Y, Yan X, Jiang C, Tao L, Wang W.
PMID: 41384105 [PubMed]


Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis.
Front Immunol
Zhong D, Liang Y, Chen Y, Su Y, Yang Q, Yan H, Huang X, Wang M.
PMID: 41383585 [PubMed - indexed for MEDLINE]


Letter to editor "A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocellular carcinoma patients: a tumor marker prognostic study".
Int J Surg
Wang B, Shen N, Xiao H.
PMID: 41382402 [PubMed - in process]


Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomized controlled trials.
Surgery
Tan HL, Zhao Y, Chua DW, Ng KYY, Lee SY, Lee JJX, Tai DW, Goh BKP, Koh YX.
PMID: 41381268 [PubMed - as supplied by publisher]


Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer.
Crit Rev Oncol Hematol
Guo X, Zhang H, Yao L, Ma W.
PMID: 41380868 [PubMed - as supplied by publisher]


The dual role of miR-184 in cancer: a systematic review of context-dependent regulation.
Mol Biol Rep
Duff B, Swadi R.
PMID: 41379397 [PubMed - indexed for MEDLINE]


A retrospective cohort study on the differential overall survival rates between surgical intervention and chemotherapy in stage IV pancreatic cancer patients.
Gland Surg
Shao S, Guo Q, Chen H, Tian B.
PMID: 41377874 [PubMed]


The role of vitamin D in gastrointestinal cancer prevention and management: a narrative review.
Ann Med Surg (Lond)
Khan NN, Shehzadi T, Hasan ZW, Panezai A, Naqash M, Rehman AU, Mohan A, Tanush D, Karimi H, Aminpoor H, Tejwaney U, Kumar S.
PMID: 41377467 [PubMed]


Efficacy and safety of celiac plexus radiotherapy in Pancreatic cancer-related pain management: a systematic review and meta-analysis.
Ann Med Surg (Lond)
Osama M, Khan H, Salman F, Baig FH, Idrees U, Abideen ZU, Odat RM, Mazhar S, Abid M, Waseem MH, Thada PK.
PMID: 41377352 [PubMed]


Development of machine learning-based prognostic models for small cell lung cancer with brain metastases: an analysis of SEER and Chinese populations.
J Thorac Dis
Guo M, Zhu J, Duan X, Ren P, Wang H, Zhang Y, Lu H, Zhao Y.
PMID: 41376903 [PubMed]


Therapeutic ambitions, diagnostic advantages, and functional divergence of pancreatic cancer-derived exosomes towards optimized disease management.
3 Biotech
Jirpu T, Talom A, Dawn B, Ghosh A.
PMID: 41376880 [PubMed]


   
   Articles 1 - 20 / 58462    Page 1 de 2924  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1